Becton, Dickinson and Company vs Pfizer, Inc. — Stock Comparison

BDX
Becton, Dickinson and Company
$149.31
▲ 0.18%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Becton, Dickinson and Company
BDX6.7/10vs 6.5/10

Q·Score Breakdown

6.7
Neutral
Overall
6.5
Neutral
6
Quality
7.4
7
Health
7
7.4
Growth
5.6
7.7
Valuation
6.7
5.2
Sentiment
5.2
BDX

Consensus analyst target of $191.46 is 28% above current price.

analyst sentiment is cautious.

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $191.46 (+28.2%)
13 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

BDX
PFE
24.4×
Trailing P/E
19.4×
11.1×
Forward P/E
9.4×
8.0%
Profit Margin
12.4%
46.8%
Gross Margin
75.8%
7.0%
ROE
8.9%
1.6%
Revenue Growth
-1.2%
28.6%
Earnings Growth
0.35
Beta
0.39
Price / Book
$42.5B
Market Cap
$149.8B
$128 – $187
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →